Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3065378 | Journal of Neuroimmunology | 2008 | 10 Pages |
Abstract
The antioxidant lipoic acid (LA) treats and prevents the animal model of multiple sclerosis (MS), experimental autoimmune encephalomyelitis (EAE). In an effort to understand the therapeutic potential of LA in MS, we sought to define the cellular mechanisms that mediate the effects of LA on human natural killer (NK) cells, which are important in innate immunity as the first line of defense against invading pathogens and tumor cells. We discovered that LA stimulates cAMP production in NK cells in a dose-dependent manner. Studies using pharmacological inhibitors and receptor transfection experiments indicate that LA stimulates cAMP production via activation of the EP2 and EP4 prostanoid receptors and adenylyl cyclase. In addition, LA suppressed interleukin (IL)-12/IL-18 induced IFNγ secretion and cytotoxicity in NK cells. These novel findings suggest that LA may inhibit NK cell function via the cAMP signaling pathway.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sonemany Salinthone, Robynn V. Schillace, Gail H. Marracci, Dennis N. Bourdette, Daniel W. Carr,